Pochamana Phisalprapa

22PUBLICATIONS
56CO-AUTHORS
Medical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)ClinimetricsHaematologyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Oct 14, 2025
Editorial: Advancing HCC Surveillance in Hepatitis B With Biomarker-Based Strategy-Authors' Reply.

Tanat Saeoui, Chayanis Kositamongkol, Pochamana Phisalprapa

|Sep 23, 2025
Cost-Utility Analysis of Biomarker-Based vs. USG + AFP Strategies for HCC Surveillance in Chronic Hepatitis B.

Tanat Saeoui, Chayanis Kositamongkol, Ratthanan Chantrakul

|Jan 17, 2025
Efficacy and Safety of Short Intravenous Hydration for Preventing Nephrotoxicity From High-Dose Cisplatin: A Randomized, Open-Label, Phase II Trial.

Apichart Jantarat, Lucksamon Thamlikitkul, Kullathorn Thephamongkhol

|Jan 09, 2025
Clinical characteristics, outcomes, and costs of COVID-19 patients in Thai hospitels: a comparative analysis based on chest X-ray findings.

Naruemit Sayabovorn, Pochamana Phisalprapa, Weerachai Srivanichakorn

|Oct 05, 2024
Evaluating the benefits of emicizumab prophylaxis for haemophilia A with inhibitors: A cost-effectiveness and budget impact analysis in Thailand's upper-middle income setting.

Kirati Kengkla, Preyanate Wilairat, Rungrote Natesirinilkul

|Apr 08, 2024
Health-related quality of life in Thai patients with chronic hepatitis B.

Ratthanan Chantrakul, Pimsiri Sripongpun, Tanawat Pattarapuntakul

Pageof 4